Topical Fluorometholone Versus Diclofenac Sodium in Cases With Perennial Allergic Conjunctivitis

Eye Contact Lens. 2015 Sep;41(5):310-3. doi: 10.1097/ICL.0000000000000127.

Abstract

Purpose: To compare the efficacy of diclofenac sodium (DS) 0.1% and fluorometholone (FL) 0.1% in patients with perennial allergic conjunctivitis.

Methods: Fluorometholone 0.1% or DS 0.1% eye drops were topically administrated 4 times daily for 4 weeks in patients with perennial allergic conjunctivitis. Assessment was conducted with a 4-point rating scale (0=none, 1=mild, 2=moderate, and 3=severe) for 4 signs and 5 symptoms.

Results: Two hundred sixty-one patients were recruited. The demographics and baseline skin prick scores between both groups were comparable. Mean baseline scores in DS and FL group were 6.77 ± 2.24 and 6.34 ± 2.10, respectively. The scores rapidly decreased to 3.28 ± 1.47 and 2.69 ± 1.44 on day 7. Diclofenac sodium expressed a slower effect compared with FL within the first 3 days of treatment (P=0.01).

Conclusions: The efficacy of topical FL and DS was comparable for the management of cases with perennial allergic conjunctivitis. However, FL led to a more rapid alleviation of signs and symptoms as compared with DS in early days after the initiation of treatment.

Publication types

  • Clinical Trial
  • Comparative Study
  • Multicenter Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Anti-Allergic Agents / administration & dosage*
  • Anti-Inflammatory Agents / administration & dosage*
  • Conjunctivitis, Allergic / drug therapy*
  • Diclofenac / administration & dosage*
  • Female
  • Fluorometholone / administration & dosage*
  • Humans
  • Male
  • Middle Aged
  • Ophthalmic Solutions / administration & dosage*
  • Severity of Illness Index
  • Young Adult

Substances

  • Anti-Allergic Agents
  • Anti-Inflammatory Agents
  • Ophthalmic Solutions
  • Diclofenac
  • Fluorometholone